Numerous clinical studies highlighted the protective and therapeutic role of neuroactive probiotics in reducing the inflammatory cascade and kynurenine levels and increasing BDNF expression via a functional crosstalk between the gut–brain axis in major depressive disorders [235,236]. Here, BDNF is linked to major depressive disorder.